Inhibition effect of small interfering RNA of connective tissue growth factor on the expression of vascular endothelial growth factor and connective tissue growth factor in cultured human peritoneal mesothelial cells

Chinese Medical Journal

Volumn 120, Issue 3, 2007, Pages 231-236

  Liu, Fu You ^a   Xiao, Li ^a   Peng, You Ming ^a   Duan, Shao Bin ^a   Liu, Hong ^a   Liu, Ying Hong ^a   Ling, Gui Hui ^a   Yuan, Fang ^a   Chen, Jun Xiang ^a   Fu, Xiao ^a   Zhu, Jian Lian ^a  

^a CENTRAL SOUTH UNIVERSITY   (China)

Author keywords

Connective tissue growth factor; Peritoneal fibrosis; RNA; Small interfering; Vascular endothelial growth factor

Indexed keywords

CONNECTIVE TISSUE GROWTH FACTOR; GLUCOSE; LIPOFECTAMINE; MESSENGER RNA; RETROVIRUS VECTOR; SMALL INTERFERING RNA; TRANSFORMING GROWTH FACTOR BETA1; VASCULOTROPIN;

ARTICLE; CELL STRAIN 3T3; CONTROLLED STUDY; FIBROSIS; HUMAN; HUMAN CELL; MESOTHELIUM CELL; PERITONEUM; PERITONEUM FIBROSIS; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; UPREGULATION; WESTERN BLOTTING;

EID: 33847042251     PISSN: 03666999     EISSN: None     Source Type: Journal    
DOI: 10.1097/00029330-200702010-00012     Document Type: Article

References (24)

1. Offner FA, Feichtinger H, Stadlmann S, Obrist P, Marth C, Klingler P, et al. Transforming growth factor-beta synthesis by human peritoneal mesothelial cells. Induction by interleukin-1. Am J Pathol 1996; 148: 1679-1688.
2. Wang T, Ghen YG, Ye RG, Mai WY, Zhen ZH, Li HQ, et al. Enhanced expression of TGF-β by peritoneal macrophages in CAPD patients. Adv Perit Dial 1995; 11: 11-14.
3. Beavis MJ, Williams JD, Hoppe J, Topley N. Human peritoneal fibroblast proliferation in 3-dimensional culture: modulation by cytokines, growth factors and peritoneal dialysis effluent. Kidney Int 1997; 51: 205-215.
4. Yung S, Liu ZH, Lai KN, Li LS, Chan T. Emodin ameliorates glucose-induced morphologic abnormalities and synthesis of transforming growth factor and fibronectin by human peritoneal mesothelial cells. Perit Dial Int 2001; 21(Suppl 3): 41-47.
5. Zhang H, Liu FY, Liu YH. Effect of TGF-beta1 stimulation on the smad signal transduction pathway of human peritoneal mesothelial cells. J Cent South Univ (Med Sci) (Chin) 2004; 29: 142-147.
6. Gunal AI, Duman S, Sen S, Unsal A, Terzioglu E, Akcicek F, et al. By reducing TGF beta 1, octreotide lessens the peritoneal derangements induced by a high glucose solution. J Nephrol 2001; 14: 184-189.
7. Duman S, Gunal AI, Sen S, Asci G, Ozkahya M, Terzioglu E, et al. Does enalapril prevent peritoneal fibrosis induced by hypertonic (3.86%) peritoneal dialysis solution? Perit Dial Int 2001; 21: 219-224.
8. Hung KY, Chen CT, Huang JW, Lee PH, Tsai TJ, Hsieh BS. Dipyridamole inhibits TGF-beta-induced collagen gene expression in human peritoneal mesothelial cells. Kidney Int 2001; 60: 1249-1257.
9. Imai H, Nakamoto H, Fucshima R, Yamanouchi Y, Ishida Y, Suzuki H. Glucocorticoid protects against the development of encapsulating peritoneal sclerosis on peritoneal dialysis. Adv Perit Dial 2002; 18: 124-130.
10. Liu FY, Ling GH, Liu H, Peng YM, Liu YH, Duan SB. Inhibiting effect of short hairpin RNA on expression of transforming growth factor-beta1 in human peritoneal mesothelial cells induced by peritoneal dialysis solution. Chin Med J 2005; 118: 1552-1556.
11. Border WA, Noble NA. TGF-β in kidney fibrosis: a target for gene therapy. Kidney Int 1997; 51: 1388-1396.
12. Lawrence DA. Transforming growth factor-beta: an overview. Kidney Int Suppl 1995; 49: s19-s23.
13. Williams JD, Craig KJ, Topley N, Von Ruhland C, Fallon M, Newman GR, et al. Morphologic changes in the peritoneal membrane of patients with renal disease. J Am Soc Nephrol 2002; 13: 470-479.
14. Mateijsen MA, van der Wal AC, Hendriks PM, Zweers MM, Mulder J, Struijk DG, et al. Vascular and interstitial changes in the peritoneum of CAPD patients with peritoneal sclerosis. Perit Dial Int 1999; 19: 517-525.
15. Szeto CC, Lai KB, Chow KM, Szeto CY, Wong TY, Li PK, et al. Differential effects of transforming growth factor-beta on the synthesis of connective tissue growth factor and vascular endothelial growth factor by peritoneal mesothelial cell. Nephron Exp Nephrol 2005; 99: e95-e104.
16. Brigstock DR. Regulation of angiogenesis and endothelial cell function by connective tissue growth factor (CTGF) and cysteine-rich 61 (CYR61). Angiogenesis 2002; 5: 153-165.
17. Chen W, Fu X, Sheng Z. Review of current progress in the structure and function of Smad proteins. Chin Med J 2002; 115: 446-450.
18. Kothapalli D, Grotendorst GR. CTGF modulates cell cycle progression in cAMP-arrested NRK fibroblasts. J Cell Physiol 2000; 182: 111-126.
19. Jedsadayanmata A, Chen CC, Kireeva ML, Lau LF, Lam SC. Activation dependent adhesion of human platelets to Cyr61 and Fisp12/mouse connective tissue growth factor is mediated through integrin alpha(IIb)beta(3). J Biol Chem 1999; 274: 24321-24327.
20. Krediet RT, Zweers MM, van der Wal AC, Struijk DG. Neoangiogenesis in the peritoneal membrane. Perit Dial Int 2000; 20 (Suppl 2): 19-25.
21. Gunal AI, Celiker H, Akpolat N, Ustundag B, Duman S, Akcicek F. By reducing production of vascular endothelial growth factor octreotide improves the peritoneal vascular alterations induced by hypertonic peritoneal dialysis solution. Perit Dial Int 2002; 22: 301-306.
22. Motomura Y, Kanbayashi H, Khan WI, Deng Y, Blennerhassett PA, Margetts PJ, et al. The gene transfer of soluble VEGF type I receptor (Flt-1) attenuates peritoneal fibrosis formation in mice but not soluble TGF-beta type II receptor gene transfer. Am J Physiol Gastrointest Liver Physiol 2005; 288: G143-G150.
23. Yoshio Y, Miyazaki M, Abe K, Nishino T, Furusu A, Mizuta Y, et al. TNP-470, an angiogenesis inhibitor, suppresses the progression of peritoneal fibrosis in mouse experimental model. Kidney Int 2004; 66: 1677-1685.
24. Inoki I, Shiomi T, Hashimoto G, Enomoto H, Nakamura H, Makino K, et al. Connective tissue growth factor binds vascular endothelial growth factor (VEGF) and inhibits VEGF-induced angiogenesis. FASEB 2002; 16: 219-221.